1. Home
  2. MYND vs CASI Comparison

MYND vs CASI Comparison

Compare MYND & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mynd.ai Inc.

MYND

Mynd.ai Inc.

HOLD

Current Price

$0.47

Market Cap

21.4M

Sector

Real Estate

ML Signal

HOLD

Logo CASI Pharmaceuticals Inc.

CASI

CASI Pharmaceuticals Inc.

HOLD

Current Price

$0.26

Market Cap

19.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYND
CASI
Founded
1998
1991
Country
United States
China
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.4M
19.7M
IPO Year
2017
2023

Fundamental Metrics

Financial Performance
Metric
MYND
CASI
Price
$0.47
$0.26
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
7.2K
15.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$0.74
52 Week High
$1.20
$3.08

Technical Indicators

Market Signals
Indicator
MYND
CASI
Relative Strength Index (RSI) 47.47 20.63
Support Level $0.41 N/A
Resistance Level $0.58 $1.07
Average True Range (ATR) 0.05 0.10
MACD 0.00 -0.04
Stochastic Oscillator 55.50 9.49

Price Performance

Historical Comparison
MYND
CASI

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: